[Effect of oridonin and bleomycin A5 combination on DNA syntheses in tumor and bone marrow cells].
D000818:Animals; D001761:Bleomycin / Q000494:pharmacology* / Q000031:analogs & derivatives; D001853:Bone Marrow / Q000378:metabolism*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D004247:DNA / Q000096:biosynthesis*; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D004224:Diterpenes / Q000494:pharmacology*; D045786:Diterpenes, Kaurane; D004357:Drug Synergism; D007941:Leukemia P388 / Q000378:metabolism*; D007942:Leukemia, Experimental / Q000378:metabolism*; D008297:Male; D051379:Mice
D004273:DNA, Neoplasm; D004224:Diterpenes; D045786:Diterpenes, Kaurane; C011959:oridonin; D001761:Bleomycin; C025703:bleomycetin; D004247:DNA